Drug Safety Risk Management Planning

Risk Management Plans (RMPs) have become a key topic in Pharmacovigilance (PV) since the 2012 European PV legislation has come into effect. Following the example of the European Union, many other countries have followed the example of the EMA and started requiring detailed plans on how the important risks of therapeutic drugs are to be minimized and/or further characterized.

Speaker: Dr. Michael Forstner | View Anytime | Price: ¤146.00 | View Details

Drug Safety Risk Management Planning

Risk Management Plans (RMPs) have become a key topic in Pharmacovigilance (PV) since the 2012 European PV legislation has come into effect. Following the example of the European Union, many other countries have followed the example of the EMA and started requiring detailed plans on how the important risks of therapeutic drugs are to be minimized and/or further characterized.

Speaker: Dr. Michael Forstner | View Anytime | Duration: 90 Minutes | Price: ¤189.00 | View Details